N.H. Code Admin. R. He-P 4035.67
Training for Ophthalmic Use of Strontium-90
Effective Oct 25, 2022(See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07 New. #8959, eff 8-7-07; ss by #10897, INTERIM, eff 7-22-15, EXPIRES: 1-18-16; ss by #11011, eff 1-15-16; ss by #13048, eff 6-2-20; ss by #13473, eff 10-25-22Former Division of Public Health Services
(a) Except as provided in He‑P 4035.71, the licensee shall require the authorized user of strontium-90 for ophthalmic radiotherapy to be a physician who:
- (1) Is an authorized user under He-P 4035.69, or the equivalent requirements of an agreement state or the Nuclear Regulatory Commission; or
(2) Has completed 24 hours of instruction applicable to the medical use of strontium-90 for ophthalmic radiotherapy, and a period of supervised clinical training in ophthalmic radiotherapy, as follows:
a. To satisfy the requirement for instruction, the classroom and laboratory training shall include:
- 1. Radiation physics and instrumentation;
- 2. Radiation protection;
- 3. Mathematics pertaining to the use and measurement of radioactivity; and
- 4. Radiation biology; and
b. To satisfy the requirement for a period of supervised clinical training in ophthalmic radiotherapy, training shall be under the supervision of an authorized user at a medical institution, clinic, or private practice and shall include the use of strontium-90 for the ophthalmic treatment of 5 individuals that includes:
- 1. Examination of each individual to be treated;
- 2. Calculation of the dose to be administered;
- 3. Administration of the dose; and
- 4. Follow-up and review of each individual’s case history.
(b) In accordance with He-P 4035.67(a) above, an authorized user who is a physician shall:
- (1) Obtain a written attestation, signed by a preceptor authorized user who meets the requirements in He-P 4035.67, He-P 4035.69, He-P 4035.71, or the equivalent requirements of an agreement state, or the Nuclear Regulatory Commission , that the individual has satisfactorily completed the requirements in He-P 4035.67(a)(2); and
- (2) Is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use.
Source. (See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07 New. #8959, eff 8-7-07; ss by #10897, INTERIM, eff 7-22-15, EXPIRES: 1-18-16; ss by #11011, eff 1-15-16; ss by #13048, eff 6-2-20; ss by #13473, eff 10-25-22